PIM1 and T-cell non-Hodgkin lymphoma: Upregulation of RUNX2 and Pim-1 was found to synergistically promote the development of T-cell lymphoma, suggesting the phosphorylation mediated by Pim-1 has a positive effect on RUNX2′s cancer-promoting function [108].